Iris.ai
- hard tech
- biotechnology
- woman founder
- horizon europe
- sustainable development goals
- analytics
- core ai
- developer tools
- ai applications
- data analytics
- generative ai
- drug development
- nordic rising star 2022
- genai applications
- speech recognition
- seal of excellence ec
- techbio
- tech for biotech & pharma
- eicfund
- research and development
- ai drug discovery
- digital pharma
- techbio drug discovery
- search engine optimization
- management system
- compbio
Financials
Estimates*
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | €350k | Angel | |
N/A | N/A | Angel | |
* | N/A | Seed | |
$2.0m | Seed | ||
€50.0k | Grant | ||
N/A | €500k | Grant | |
€900k | Grant | ||
N/A | €700k | Secondary | |
N/A | €3.6m | Secondary | |
* | €2.4m | Grant | |
N/A | Early VC | ||
* | €7.6m | Growth Equity VC | |
Total Funding | $15.0m |
Recent News about Iris.ai
EditDeveloper of a research assistance tool designed to help search and map millions of open-access research papers. The company's tool uses a combination of keyword extraction, word embeddings, neural topic modeling, and artificial intelligence to review research papers or patents, find the right documents, extract all their key data or identify the pieces of knowledge, enabling research teams to conduct secondary scientific research with the assistance provided by a search engine that deploys natural language processing algorithms.
Keywords: Software, Fintech, Security and Connectivity, Ai Science Assistant, Ai-Powered Drug Discovery, Artificial Intelligence System, Language Processing Algorithm, Scientific Research, Systematic Mapping Study.